항-알파(V)베타 항체를 함유하는 약제학적 조성물 및 투약 요법

항-αvβ6 항체 또는 이의 αvβ6-결합 단편의 제형 및 투약 요법이 제공된다. 이들 제형은, 예를 들어, 섬유증(예를 들어, 특발성 폐 섬유증), 급성 폐 손상 및 급성 신장 손상의 치료에서의 용도를 발견한다. Formulations and dosage regimens of an anti-αvβ6 antibody or αvβ6-binding fragment thereof are provided. These formulations find use in the treatment of e.g., fibrosis (e.g., idiop...

Full description

Saved in:
Bibliographic Details
Main Authors GOVINDAN GEETHA, MCGRATH MARGARET, ESTEY TIA BRIE, SALUJA SONAL, GUPTA KAPIL
Format Patent
LanguageKorean
Published 28.04.2020
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract 항-αvβ6 항체 또는 이의 αvβ6-결합 단편의 제형 및 투약 요법이 제공된다. 이들 제형은, 예를 들어, 섬유증(예를 들어, 특발성 폐 섬유증), 급성 폐 손상 및 급성 신장 손상의 치료에서의 용도를 발견한다. Formulations and dosage regimens of an anti-αvβ6 antibody or αvβ6-binding fragment thereof are provided. These formulations find use in the treatment of e.g., fibrosis (e.g., idiopathic pulmonary fibrosis), acute lung injury, and acute kidney injury.
AbstractList 항-αvβ6 항체 또는 이의 αvβ6-결합 단편의 제형 및 투약 요법이 제공된다. 이들 제형은, 예를 들어, 섬유증(예를 들어, 특발성 폐 섬유증), 급성 폐 손상 및 급성 신장 손상의 치료에서의 용도를 발견한다. Formulations and dosage regimens of an anti-αvβ6 antibody or αvβ6-binding fragment thereof are provided. These formulations find use in the treatment of e.g., fibrosis (e.g., idiopathic pulmonary fibrosis), acute lung injury, and acute kidney injury.
Author MCGRATH MARGARET
SALUJA SONAL
GOVINDAN GEETHA
GUPTA KAPIL
ESTEY TIA BRIE
Author_xml – fullname: GOVINDAN GEETHA
– fullname: MCGRATH MARGARET
– fullname: ESTEY TIA BRIE
– fullname: SALUJA SONAL
– fullname: GUPTA KAPIL
BookMark eNrjYmDJy89L5WQIfjt1re6bqT1ve3o0wjRfb1rwtrlBASj2ZtOW10v3AFkr3sxZ8HbqjNddUxTeTN37ZsGct1NnvlnQqPBm4YY3LRtfr9mj8HpDv8LbjjVAWYU3s6a83jSVh4E1LTGnOJUXSnMzKLu5hjh76KYW5MenFhckJqfmpZbEewcZGRgZGBiYmBiYmTkaE6cKAP-pUTw
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID KR20200044066A
GroupedDBID EVB
ID FETCH-epo_espacenet_KR20200044066A3
IEDL.DBID EVB
IngestDate Fri Jul 19 15:01:22 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Korean
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_KR20200044066A3
Notes Application Number: KR20207008234
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200428&DB=EPODOC&CC=KR&NR=20200044066A
ParticipantIDs epo_espacenet_KR20200044066A
PublicationCentury 2000
PublicationDate 20200428
PublicationDateYYYYMMDD 2020-04-28
PublicationDate_xml – month: 04
  year: 2020
  text: 20200428
  day: 28
PublicationDecade 2020
PublicationYear 2020
RelatedCompanies BIOGEN MA INC
RelatedCompanies_xml – name: BIOGEN MA INC
Score 3.242228
Snippet 항-αvβ6 항체 또는 이의 αvβ6-결합 단편의 제형 및 투약 요법이 제공된다. 이들 제형은, 예를 들어, 섬유증(예를 들어, 특발성 폐 섬유증), 급성 폐 손상 및 급성 신장 손상의 치료에서의 용도를 발견한다. Formulations and dosage regimens of an...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title 항-알파(V)베타 항체를 함유하는 약제학적 조성물 및 투약 요법
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200428&DB=EPODOC&locale=&CC=KR&NR=20200044066A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTFONDdOMTXXNTMySdM1STECloOphim65skmwMo70cLCMgU0DunrZ-YRauIVYRrBxJAD2wsDPie0HHw4IjBHJQPzewm4vC5ADGK5gNdWFusnZQKF8u3dQmxd1KC9YyNwF0DNxcnWNcDfxd9ZzdnZ1jtIzS8IIge6XtnMzJGZgRXUkAadtO8a5gTal1KAXKm4CTKwBQDNyysRYmDKzhdm4HSG3b0mzMDhC53yBjKhua9YhCH47dS1um-m9rzt6dEI03y9acHb5gYFoNibTVteL90DZK14M2fB26kzXndNUXgzde-bBXPeTp35ZkGjwpuFG960bHy9Zo_C6w39Cm871gBlFd7MmvJ601RRBmU31xBnD12g6-LhgRHvHYTsFWMxBpa8_LxUCQYF82TjNKPENEvTNGCbwjI50dI01SjVwizFyCzRHNgMMJRkkMFnkhR-aWkGLhAXNI9iZCHDwFJSVJoqC6yOS5LkwKEIAKqbpKc
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTFONDdOMTXXNTMySdM1STECloOphim65skmwMo70cLCMgU0DunrZ-YRauIVYRrBxJAD2wsDPie0HHw4IjBHJQPzewm4vC5ADGK5gNdWFusnZQKF8u3dQmxd1KC9YyNwF0DNxcnWNcDfxd9ZzdnZ1jtIzS8IIge6XtnMzJGZgdUcdD4vqPEU5gTal1KAXKm4CTKwBQDNyysRYmDKzhdm4HSG3b0mzMDhC53yBjKhua9YhCH47dS1um-m9rzt6dEI03y9acHb5gYFoNibTVteL90DZK14M2fB26kzXndNUXgzde-bBXPeTp35ZkGjwpuFG960bHy9Zo_C6w39Cm871gBlFd7MmvJ601RRBmU31xBnD12g6-LhgRHvHYTsFWMxBpa8_LxUCQYF82TjNKPENEvTNGCbwjI50dI01SjVwizFyCzRHNgMMJRkkMFnkhR-aXkGTo8QX594H08_b2kGLpAUaE7FyEKGgaWkqDRVFlg1lyTJgUMUAIe2p5Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=%ED%95%AD-%EC%95%8C%ED%8C%8C%28V%29%EB%B2%A0%ED%83%80+%ED%95%AD%EC%B2%B4%EB%A5%BC+%ED%95%A8%EC%9C%A0%ED%95%98%EB%8A%94+%EC%95%BD%EC%A0%9C%ED%95%99%EC%A0%81+%EC%A1%B0%EC%84%B1%EB%AC%BC+%EB%B0%8F+%ED%88%AC%EC%95%BD+%EC%9A%94%EB%B2%95&rft.inventor=GOVINDAN+GEETHA&rft.inventor=MCGRATH+MARGARET&rft.inventor=ESTEY+TIA+BRIE&rft.inventor=SALUJA+SONAL&rft.inventor=GUPTA+KAPIL&rft.date=2020-04-28&rft.externalDBID=A&rft.externalDocID=KR20200044066A